Jo. Schiele et U. Schwabe, CHARACTERIZATION OF THE ADENOSINE RECEPTOR IN MICROVASCULAR CORONARY ENDOTHELIAL-CELLS, European journal of pharmacology. Molecular pharmacology section, 269(1), 1994, pp. 51-58
In the present work we studied the effect of adenosine and various ade
nosine analogues on cAMP level in guinea pig coronary endothelial cell
s of microvascular origin. The tested adenosine agonists mediate a con
centration-dependent increase in cAMP level. The rank order of potency
was 5'-N-ethylcarboxamidoadenosine (NECA)> CGS 21680 > N-6 phenylisop
ropyladenosine (R-PIA)> 2-chloro-N-6-cyclopentyladenosine (CCPA) which
is typical for an adenosine A(2) receptor. Their respective concentra
tions for half maximal stimulation of cAMP formation were 0.36 mu M, 0
.82 mu M, 4.7 mu M and 9.8 mu M. The tested agonists showed difference
s in efficacy, NECA being the most efficacious. R-PIA, CCPA and adenos
ine were less efficacious, suggesting partial agonism. The efficacy of
adenosine was unchanged by the addition of the nucleoside transport i
nhibitor S(4-nitrobenzyl)-6-thioinosine (NBTI, 10 mu M) suggesting tha
t inhibition of adenylyl cyclase through P-site activation is not resp
onsible for the observed low efficacy of adenosine. We could demonstra
te CGS 21680 activation of adenylyl cyclase in a peripheral receptor.
We therefore suggest that the endothelial adenosine receptor resembles
the striatal adenosine A(2), receptor.